EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Severity of COVID‐19 infection in pregnancy and adverse maternal and neonatal outcomes: A retrospective study in a tertiary center

Paul Naseef, Ayman Abou Elnour, Ahmed Ramy

Reproductive, Female and Child Health · 2023

DOI: 10.1002/rfc2.19 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction To estimate the association between the severity of maternal SARS‐CoV2 disease and adversity of maternal and neonatal outcomes. Methods A retrospective single‐site descriptive study was conducted, where the records of pregnant women, universally screened for COVID‐19 infection, with laboratory‐confirmed SARS‐CoV2 disease during the period from March 2020 to March 2021 were reviewed. Patients were divided into two groups: an asymptomatic/mild disease group and a moderate/severe disease group. Maternal outcomes, including the incidence of pregnancy‐induced hypertension (PIH)/pre‐eclampsia, cesarean section (CS) rates, maternal intensive care unit (ICU) admission rates, and neonatal outcomes, including preterm birth, low birth weight, and neonatal ICU (NICU) admission rates, were compared in both study groups. Results A total of 352 patients were included with 87 (24.7%) having a moderate/severe disease. In this group, the incidence of preterm birth (

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →